deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT04629664

FX-322 in Adults With Severe Sensorineural Hearing Loss

A Phase 1b, Prospective, Randomized, Double-Blind, Placebo- Controlled, Single-Dose, Multicenter, Safety Study of FX-322 Administered by Intratympanic Injection in Adults With Severe Sensorineural Hearing Loss

Sponsor: Frequency Therapeutics

Conditions Hearing Loss, Sensorineural Noise Induced Hearing Loss Sudden Hearing Loss
Interventions FX-322 Placebo
Updated 8 times since 2020 Last updated: Jan 31, 2022 Started: Nov 2, 2020 Primary completion: May 26, 2021 Completion: Sep 20, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Hearing Loss, Sensorineural and Noise Induced Hearing Loss, this trial is completed. The trial is conducted by Frequency Therapeutics and has accumulated 8 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotRecruiting~Feb 2021 – ~May 2021 · 3 months · monthly snapshotRecruiting~May 2021 – ~Sep 2021 · 4 months · monthly snapshotRecruiting~Sep 2021 – ~Feb 2022 · 5 months · monthly snapshotActive Not Recruiting~Feb 2022 – ~Jul 2024 · 29 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Feb 2022 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  4. Sep 2021 — Feb 2022 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  5. May 2021 — Sep 2021 [monthly]

    Recruiting PHASE1

▶ Show 3 earlier versions

  1. Feb 2021 — May 2021 [monthly]

    Recruiting PHASE1

  2. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE1

  3. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

    First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Frequency Therapeutics
Data source: Frequency Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations